# A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

> **NCT00363116** · PHASE4 · COMPLETED · sponsor: **University of Cincinnati** · enrollment: 298 (actual)

## Conditions studied

- Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients

## Interventions

- **DRUG:** Daclizumab

## Key facts

- **NCT ID:** NCT00363116
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-04
- **Primary completion:** 2004-12
- **Final completion:** 2004-12
- **Target enrollment:** 298 (ACTUAL)
- **Last updated:** 2013-10-25

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00363116

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00363116, "A Trial of Two Daclizumab Dosing Strategies vs. No Induction Treatment With Tacrolimus, Mycophenolate Mofetil , & Steroids for the Prevention of Acute Allograft Rejection in Simultaneous Kidney/Pancreas Transplant Recipients". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00363116. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*